The Food and Drug Administration announced Friday that low levels of a cancer-causing chemical have been found in samples of the antidandruff drug Zantac, colon and uterine cancer.
According to the FDA, low NDMA levels were found in ranitidine samples, a drug used to treat and prevent heartburn by reducing gastric acidity. It is distributed under the brand name Zantac.
It is unclear where the contamination came from. NDMA is the same chemical that has led to multiple drug-related drug recalls over the past year.
There is currently no recall of Zantac or ranitidine-containing medicines Antacids pose a health risk to the millions of people who take them, and it has been stated that the use of heartburn should stop only when more is needed is known.
Other available on the market heartburners such as Prevacid, Nexium and Prilosec contain different ingredients and are not included in this warning.
"Patients should be confident that their medicines are as safe as possible and that the benefits of ingesting them outweigh any risk to their health," said Drs. Janet Woodcock, director of the FDA Center for Drug Evaluation and Research, in a statement.
"Although NDMA can cause harm According to the Centers for the Control and Prevention of Diseases, NDMA was found in tobacco smoke, chewing tobacco and sausages such as bacon.
Ranitidine is sold over the counter as a heartburn drug, but is also used to treat Gastric ulcers and gastroesophageal reflux disease were used.
Follow NBC HEALTH on Twitter & Facebook.